About The ASCO Post
Rights and Permissions
In the Clinic
View By Issue
2019 ASTRO Annual Meeting
IASLC 2019 World Conference on Lung Cancer
2019 Quality Care Symposium
2019 Debates and Didactics in Hematology and Oncology
2019 NCCN Policy Summit
Biomarkers in Immunotherapy
IMPROVING NSCLC OUTCOMES
Methotrexate–Induced Kidney Injury
Today In Oncology
Cost of Treatment, Prior Authorization of Treatment Plans May Cause Barriers to Care
FDA Grants Approval to Lenvatinib/Pembrolizumab in Advanced Endometrial Cancer, Announces Project Orbis
Olaparib Improves Outcomes in Ovarian Cancer
Does PTSD Increase the Risk of Developing Ovarian Cancer?
Does the Addition of Bevacizumab to Erlotinib in Advanced EGFR-Mutant NSCLC Improve PFS?
Most Read Stories
When Can Patients With Gleason 6 Prostate Cancer Safely Undergo Active Surveillance?
WCLC 2019: KEYNOTE-024 Survival Update Shows Benefit With Pembrolizumab vs Chemotherapy in Advanced NSCLC
Meta-analysis of Chemotherapy and Hormonal Treatments for Postmenopausal Women With Metastatic Breast Cancer
ASTRO 2019: Patterns of Disease Progression in Patients With Unresectable Stage III NSCLC: Analysis of the PACIFIC Trial
Management of HER2-Positive Breast Cancer: Business as Usual?
Most Viewed Videos
Cristina Merkhofer, MD, MHS, on NSCLC: Survival Impact of Taking Part in a Clinical Trial
Grace C. Hillyer, EdD, MPH, on Enrolling Patients in Clinical Trials: Improving Clinician-Patient Communication
Nadine Housri, MD, on Online Tumor Boards: A New Resource for Practicing Oncologists
Elena Martinez, PhD, MPH, on Diversity in Precision Oncology
Robert A. Figlin, MD, on RCC: Results From the ADAPT Trial
© 2019 HSP News Service, L.L.C.